ArticleSignal transduction and targeted therapy2020

The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer.

Shenghui HePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.